Research Categories
- Anesthesia
- Arthroscopy
- Biologics/Biomaterials
- Cancer Devices
- Cardiovascular
- Cosmetic Devices
- Dental
- Diabetes
- Diagnostics
- Dialysis
- Drug Delivery
- Ear, Nose, Throat
- Endoscopy
- Gastrointestinal (GI)
- General Surgery
- Gynecology Devices
- Healthcare IT
- Hearing Devices
- Imaging
- Immunology
- Infusion Therapy
- Laparoscopy
- Minimally Invasive Surgery
- Neurology Devices
- Oncology
- Operating Room Equipment
- Ophthalmics Devices
- Orthopedics
- Patient Monitoring
- Peripheral Vascular
- Respiratory Devices
- Robotics & Navigation
- Sleep Apnea & Diagnostics
- Spine
- Stents
- Tissue Repair
- Urology
- Vascular Access
- Video Hi-Tech
- Women's Health
- Wound Care
Cardiac Surgery
The cardiac surgery market reports include research on tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter heart valve repair (THVR) devices, transcatheter heart valve replacement (THVI) devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), transmyocardial revascularization (TMR) devices, ventricular assist devices (VADs), intra-aortic balloon pumps, artificial heart replacement devices, patent foramen ovale (PFO), atrial septal defect (ASD) devices, ventricular septal defect (VSD) devices and left atrial appendage (LAA) devices.
iData’s market research will provide insights into the following questions:
- How is COVID-19 affecting the global Cardiac Surgery and Heart Valve market?
- What is the Cardiac Surgery and Heart Valve Devices market size in the U.S.?
- What factors are impacting the Cardiac Surgery and Heart Valve Devices market in Japan?
- What is the number of total procedures in the Cardiac Surgery market? What procedure volumes are on the rise or decline within the segments in Australia?
- What are the major developments in the Cardiac Surgery market in the U.K.? What impact did these have on the market share in the U.K.?
- What is the Cardiac Surgery instruments market size of China? Which competitors hold more market share within the cardiac surgery instruments market in China?
Find your answers in the reports for: Asia Pacific, China, European, U.S. or Global
Showing 1–12 of 16 results
Cardiac Surgery Market Size, Share & Trends Analysis | Global | 2024-2030 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 20 more
The full report suite on the global market for cardiac surgery device includes the tissue heart valve, mechanical heart valve, annuloplasty repair device, transcatheter mitral valve repair, transcatheter heart valve replacement, cerebral embolic protection device, balloon valvuloplasty, on-pump coronary artery bypass (ONCAB) device, off-pump coronary artery bypass (OPCAB) device, autotransfusion device, endoscopic vessel harvesting device, anastomosis assist device, ventricular assist device, intra-aortic balloon device, artificial heart replacement device, patent foramen ovale closure device, patent ductus arteriosus closure device, atrial and ventricular septal defect closure device, left atrial appendage closure device, preshaped guidewire, transmyocardial revascularization device and extracorporeal membrane oxygenation (ECMO) markets.
more...Heart Defects Closure Device Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Segmented by: Patent Foramen Ovale Closure Device Market and Atrial & Ventricular Septal Defect Closure Device Markets
The global Heart Defects Closure Device Market Reportcontains analysis for Patent Foramen Ovale Closure Devices and Atrial & Ventricular Septal Defect Closure Devices. The global patent foramen ovale closure market and global atrial & ventricular septal defect closure markets are expected to reach $322.7M and $226.2M by 2027, respectively.
more...Tissue Heart Valve Market Analysis | Global | 2024-2030 | MedCore | Segmented by: Stented Tissue Heart Valves, Stentless Tissue Heart Valves, and 1 more
The global Heart Defects Closure Device Market Reportcontains analysis for Patent Foramen Ovale Closure Devices and Atrial & Ventricular Septal Defect Closure Devices. The global patent foramen ovale closure market and global atrial & ventricular septal defect closure markets are expected to reach $322.7M and $226.2M by 2027, respectively.
more...On-Pump and Off-Pump Coronary Artery Bypass Device Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: ONCAB Disposables Market, Perfusion System Market, Stabilizer Device Market, Positioner Device Market
Overall, the global on-pump coronary artery bypass device market was valued at $550 million in 2023. This is expected to increase over the forecast period at a CAGR of 3% to reach $680 million. The global off-pump coronary artery bypass device market was valued at $230 million in 2023. This is expected to decrease at a CAGR of –0.7% to $220 million over the forecast period.
more...Surgical Heart Valve Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Segmented by: Mechanical Heart Valve Market, Tissue Heart Valve Replacement Market and Annuloplasty Repair Device Market
Surgical heart valve replacement procedures can be performed using tissue or mechanical heart valves. Tissue valve procedures can be classified by valve replaced (aortic, mitral, tricuspid or pulmonary), by material (xenograft or allograft) or device type (stented, sutureless or stentless). Mechanical valves can be classified by valve replaced (aortic, mitral, tricuspid or pulmonary) or by conduit (with conduit or without conduit).
more...Ventricular Assist Device and Intra-Aortic Balloon Pump Device Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Includes: Percutaneous VAD Market, Implantable VAD Market, IABP Catheter Market and IABP Console Market
Ventricular assist devices (VADs) are used to aid a failing heart by supplementing the pumping function of the heart. VADs are often used in patients with advanced heart failure (HF). HF is a chronic disease that occurs when degeneration of the heart muscle reduces the pump power of the heart, which causes the heart to become too weak to pump blood at a level sufficient to meet the body’s demands.
more...TAVR/TAVI, Cerebral Embolic Protection, and Pre-Shaped Guidewire Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Includes 3 Reports
Global TAVI/TAVR, CEPD, and Pre-Shaped Guidewire markets are expected to increase to reach $8.4 billion, $492.3 million, and $70.9 million. The analysis includes in-depth procedure numbers, which will seemingly increase over the forecast period, along with the impact of COVID-19 on the procedure volume.
more...